Trademark Search in Canada

STOCKHOLM3

View On IC.GC.CA

REGISTERED

on 1 Mar 2024

Last Applicant/ Owned by

A3P BIOMEDICAL AB

Kungsgatan 24 SE-111 35 Stockholm

Serial Number

2126375 filed on 9^th Feb 2021

Registration Number

TMA1223676 registered on 1^st Mar 2024

Registration expiry Date

9^th Feb 2031

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

M5H3Y2

STOCKHOLM3

Trademark usage description

medical preparations and articles, namely, diagnostic blood test for risk stratification of prostate cancer; diagnostic preparations for medical purpo Read More

Classification Information

Class [005]
Medical preparations and articles, namely, diagnostic blood test for risk stratification of prostate cancer; diagnostic preparations for medical purposes for detecting genetic predispositions; diagnostic biomarker reagents for medical purposes; diagnostic preparations for in vitro testing for medical use; reagents for use in diagnostic tests for medical purposes; diagnostic testing materials for medical use, namely, medical diagnostic reagents and medical diagnostic assays for testing body fluids for determining the presence of certain protein and genetic markers; diagnostic test materials for prostate cancer, namely, medical diagnostic reagents and medical diagnostic assays for testing body fluids for medical determination of risk stratification of prostate cancer; diagnostic preparations for medical laboratory use.

Classification kind code

Class [009]
Medical preparations and articles, namely, diagnostic blood test for risk stratification of prostate cancer; diagnostic preparations for medical purposes for detecting genetic predispositions; diagnostic biomarker reagents for medical purposes; diagnostic preparations for in vitro testing for medical use; reagents for use in diagnostic tests for medical purposes; diagnostic testing materials for medical use, namely, medical diagnostic reagents and medical diagnostic assays for testing body fluids for determining the presence of certain protein and genetic markers; diagnostic test materials for prostate cancer, namely, medical diagnostic reagents and medical diagnostic assays for testing body fluids for medical determination of risk stratification of prostate cancer; diagnostic preparations for medical laboratory use.

Classification kind code

Class [010]
Medical preparations and articles, namely, diagnostic blood test for risk stratification of prostate cancer; diagnostic preparations for medical purposes for detecting genetic predispositions; diagnostic biomarker reagents for medical purposes; diagnostic preparations for in vitro testing for medical use; reagents for use in diagnostic tests for medical purposes; diagnostic testing materials for medical use, namely, medical diagnostic reagents and medical diagnostic assays for testing body fluids for determining the presence of certain protein and genetic markers; diagnostic test materials for prostate cancer, namely, medical diagnostic reagents and medical diagnostic assays for testing body fluids for medical determination of risk stratification of prostate cancer; diagnostic preparations for medical laboratory use.

Classification kind code

Class [042]
Computer programming in the medical field; software development, programming and implementation; web hosting; providing temporary use of non-downloadable software for use in medical diagnostics and analyzing clinical data for scientific and medical research; scientific and technology services, namely, diagnostic medical testing services for others for scientific research purposes; medical and pharmacological research services; clinical trials; scientific research for medical purposes in the area of cancerous diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information on clinical studies via an interactive website; medical research laboratory services; clinical trials.

Classification kind code

Class [044]
Health care services, namely, providing diagnostic tests for prostate cancer; genetic testing for medical purposes; medical analysis services for the diagnosis of cancer; medical diagnostic services; medical laboratory services for the analysis of blood samples taken from patients; medical testing for diagnostic and treatment purposes; medical diagnostic services; diagnostic tests for prostate cancer; online services relating to medical and diagnostic tests, namely prostate cancer tests; prostate cancer screening services; medical testing services relating to prostate cancer; prostate cancer diagnostics; prostate cancer screening services; blood bank services; medical laboratory services for the analysis of blood samples taken from patients; medical testing of blood; services for the testing of blood; medical testing for diagnostic or treatment purposes; medical diagnostic services; medical services for the diagnosis of conditions of the human body; medical analysis for the diagnosis and treatment of persons; medical testing services relating to the diagnosis and treatment of disease; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; providing information relating to medical results and diagnostic tests, namely prostate cancer tests; providing information relating to medical test results; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical laboratory services for the analysis of samples and blood samples taken from patients; leasing of medical equipment; information, advisory and consultancy services in the field of prostate cancer diagnostic testing; information, advisory and consultancy services in the field of medical testing services.

Classification kind code

Mark Details

Serial Number

2126375

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 24^th Nov 2022	Search Recorded
Submitted for opposition 20 on 24^th Nov 2022	Examiner's First Report
Submitted for opposition 223 on 24^th Nov 2022	Total Provisional Refusal
Submitted for opposition 256 on 13^th Jun 2022	Notification of Possible Opposition Sent
Submitted for opposition 48 on 15^th Dec 2021	Agent Changed
Submitted for opposition 257 on 12^th Aug 2021	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 11^th Aug 2021	Created
Submitted for opposition 31 on 11^th Aug 2021	Formalized
Submitted for opposition 228 on 9^th Feb 2021	International Registration
Submitted for opposition 30 on 9^th Feb 2021	Filed